← Back to headlines
Canaccord Lifts Price Target on Biodesix Due to Raised Revenue Assumptions
Canaccord has raised its price target for Biodesix (BDSX), citing increased revenue assumptions for the company. This revision indicates an improved financial outlook for Biodesix.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
